2023 AUA Recaps : Episode 3

Dr. Bradley Gill on key BPH research from AUA 2023

Bradley Gill, MD, MS, recaps several presentations on benign prostatic hyperplasia from the 2023 American Urological Association Annual Meeting in Chicago, Illinois.

In this video, Bradley Gill, MD, MS, recaps several presentations on benign prostatic hyperplasia from the 2023 American Urological Association Annual Meeting in Chicago, Illinois. Gill is an associate professor of urology at Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.

The following research is discussed:

1. MP76-02 (Kaplan et al): At 4 years, Optilume BPH has the highest sustained improvement in peak flow (Qmax) of any minimally invasive BPH therapy

2. MP76-04 (Elterman): Prostate volume reduction by Rezum water vapour thermal therapy in glands <80 cc and >80 cc

3. MP76-07 (Lee et al): The impact of previous benign prostatic hypertrophy surgery on water ablation therapy: A comparison of safety and efficacy

4. Society of Benign Prostate Disease meeting highlights

Related Videos
Katie S. Murray, DO, answers a question during a Zoom video interview
Kelly L. Stratton, MD, FACS, answers a question during a Zoom video interview
Dr. Nour Abdallah in an interview with Urology Times
Dr. Howard Goldman in an interview with Urology Times
Dr. Smita De in an interview with Urology Times
Doctor receiving patient in office | Image Credit © Africa Studio - stock.adobe.com
Blurred interior of hospital | Image credit: © jakkapan - stock.adobe.com
Raevti Bole, MD, answers a question during a Zoom video interview
Sarah Vij, MD, answers a question during a Zoom video interview
Related Content
© 2023 MJH Life Sciences

All rights reserved.